Le Vol 78 - N°4 - JUILLET AOUT 2023 est en ligne

Au sommaire

• Editorials

  • ·Hydroxychloroquine and COVID-19: The endgame!

    Dominique Deplanque

  • ·Evidence-based medicine: Friend and foe

    Christian Funck-Brentano

  • ·Propofol and infectious complications

    Joelle Micallef, Tessa Pietri

• Clinical research

  • ·Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patient
  • Rémy Boussageon, Clara Blanchard, Elodie Charuel, Thibault Menini, Bruno Pereira, Florian Naudet, Behrouz Kassai, François Gueyffier, Michel Cucherat, Hélène Vaillant-Roussel

• Pharmacokinetics

  • ·Effects of missed dose and delayed dose quetiapine on its pharmacokinetics and pharmacodynamics

    Janthima Methaneethorn

• Pharmacovigilance

  • ·Complications infectieuses liées à l’utilisation du propofol : une nouvelle série de cas et revue de la littérature

    Badreddine Moukafih, Soufiane El Marrakchi, Ismail Bennani, Mounia Lakhdar-Idrissi, Moustapha Hida, Abdeslam El Kartouti, Sanae Achour

  • ·Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation

    Long Mei, Sa Li, Qianqian Fan, Bin Zhao, Dan Mei, Roxane Took, Jiancun Zhen

  • ·Drug-related risk of hospital readmission in children with chronic diseases, a systematic review

    Elham Jaberi, Behrouz Kassai, Anick Berard, Guillaume Grenet, Kim An Nguyen

  • ·Adverse effect of Pneumocystis Jirovecii infection associated with rituximab therapy for autoimmune disease are more frequently reported in older vs. younger patient

    Léa Lemoine, Marie Sara Agier, Alexandra Audemard-Verger, Laurent Chouchana, Joëlle Michot, Annie Pierre Jonville-Béra, Francois Maillot

  • ·Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic

    Pauline Lory, Sandrine Combret, Joelle Michot, Gwenaelle Veyrac, Laurent Chouchana, Aurélie Grandvuillemin

• Clinical research

  • ·OLGA, plateforme numérique d’aide au pilotage de réseaux nationaux de recherche en santé : un modèle pour les organisations complexes ?

    Vincent Diebolt, Christine Trillou, Johanna Steen, Mélanie Rigodanzo, Allan Wilsdorf, Sarhan Yaïche

• Letters to Editor

  • ·Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted

    Damien Barraud, Lonni Besançon, Elisabeth M. Bik, Eric Billy, Franck Clarot, Fabrice Frank, Anthony Guihur, David Hajage, Karine Lacombe, Hervé Maisonneuve, Mathieu Molimard, Matthieu Mulot, Alexander Samuel

  • ·Letrozole induced visual hallucination

    Ahmed Zaiem, Khouloud Ferchichi, Ghozlane Lakhoua, Widd Kaabi, Sana Rebii Debbiche, Imen Aouinti, Ons Charfi, Sihem El Aidli

  • ·An atypical Ramsey Hunt syndrome after covid 19 immunization

    Ghozlane Lakhoua, Ons Charfi, Sana Dabbeche, Ahmed Zaiem, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli

  • ·Les contraceptifs hormonaux en interaction avec les thymorégulateurs antiépileptiques et le lithium : quelles implications thérapeutiques ?

    Youssef Ouazzani Housni Touhami, Yassine Benhaddouch, Zakaria Hammani, Amine Bout, Chadya Aarab, Rachid Aalouane

  • ·De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine

    Ahmed Zaiem, Mouna Daldoul, Talel Badri, Ghozlane Lakhoua, Widd Kaabi, Sana Rebii Debbiche, Sarrah Kastalli, Imen Aouinti, Ons Charfi, Sihem El Aidli

  • ·About two cases of possible topical steroid withdrawal reaction

    Johana Béné, Flore Durieux, Sandrine Bergeron, Camille Potey, Bénédicte Lebrun-Vignes, Delphine Staumont-Sallé, Sophie Gautier

  • ·Atypical neurological toxicity attributed to oxaliplatin

    Wiem Daly, Ghozlane Lakhoua, Ahmed Zaiem, Ons Charfi, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli

  • ·Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine

    Taieb Ach, Fatma Kammoun, Hamza El Fekih, Nassim Ben Haj Slama, Siwar Kahloun, Fatma Ben Fredj, Chédia Laouani, Koussay Ach

  • ·Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

  • ·The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions

    Taieb Ach, Mounira El Euch

  • ·Benralizumab-induced interstitial granulomatous dermatitis: A case report

    Farid Mankouri, Laurie Gosse, Tom Handwerk, Benjamin Guyot, Laurie Pahus, Pascal Chanez, Safia Abed, Thierry Boye, Jean-Jacques Morand, Aude Valois

  • ·Severe hepatitis after sevoflurane anesthesia in an 8-month old child with a Down syndrome: Case report and review of the literature

    Lucas Aghnatios, Clément Karsenty, Caroline Viard, Claire de Canecaude, Geneviève Durrieu

  • ·La crise climatique, un argument de poids pour améliorer la déclaration des liens d’intérêt

    Nicolas Faure

  • ·Only blame SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out

    Josef Finsterer, Fulvio A. Scorza

  • ·Response to Letter “Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out”

    Morgane Chamboux, Corinne Simon, Frédérique Beau-Salinas, Anaïs Maurier, Marie Sara Agier, Eve Marie Thillard, Bérenger Largeau, Annie-Pierre Jonville-Bera

Les instructions aux auteurs évoluent et s'adaptent à l'IA
Vous pouvez les consulter en suivant le lien ci dessous

Instructions to authors are evolving and adapting to AI
You can view them by following the link here enclosed

 Instructions to authors July 2023

LE FACTEUR D'IMPACT 2022 VIENT D'ÊTRE PUBLIÉ ET AFFICHE DÉSORMAIS UN RÉSULTAT DE 2,6.